Micro Developing Active

Eli Lilly élargit l'accès à Zepbound pour une croissance à long terme

Score
0,5
Vélocité
▲ 0,0
Articles
9
Sources
4

Résumé

Un article appartient à ce récit s'il traite de l'expansion de l'accès à Zepbound par Eli Lilly et de ses perspectives de croissance à long terme.

Articles Liés

Jim Cramer Likes Eli Lilly’s (LLY) New Deal

Yahoo Finance · Avr 05, 2026
Mixed

Eli Lilly's One-Two Punch Could Knock Novo Nordisk Out of the Obesity Drug Fight

Nasdaq · Avr 04, 2026
Mixed

Eli Lilly secures long-awaited FDA approval for its obesity pill. Here's what to know

CNBC · Avr 01, 2026
Mixed

The cutthroat battle for the US weight-loss drug market

BBC Business · Mar 23, 2026
Mixed

Eli Lilly and Company (LLY) Expands Zepbound Access as Pricing Reforms Boost Long-Term Growth Outlook

Yahoo Finance · Mar 22, 2026
Mixed

Sources

Eli Lilly's One-Two Punch Could Knock Novo Nordisk Out of … Nasdaq
Jim Cramer Likes Eli Lilly’s (LLY) New Deal Yahoo Finance
Is Eli Lilly and Company (LLY) The Best Pharma Stock … Yahoo Finance
Eli Lilly secures long-awaited FDA approval for its obesity pill. … CNBC
Eli Lilly reaches $2.75 billion deal with Insilico to bring … CNBC
Here's How Much Upside Eli Lilly Stock Has, According to … Yahoo Finance
The cutthroat battle for the US weight-loss drug market BBC Business
Eli Lilly and Company (LLY) Expands Zepbound Access as Pricing … Yahoo Finance

Chronologie

Dernière mise à jour Mar 22, 2026